Evidence map›Paper›PMID 35558043›Full record

ArticleRSC advances2018

Aza-BODIPY based polymeric nanoparticles for cancer cell imaging.

Kantapat Chansaenpak, Similan Tanjindaprateep, Nipha Chaicharoenaudomrung, Oratai Weeranantanapan, Parinya Noisa, Anyanee Kamkaew

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Kantapat ChansaenpakNational Nanotechnology Center, National Science and Technology Development Agency Thailand Science Park Pathum Thani 12120 Thailand.
Similan TanjindaprateepSchool of Chemistry, Institute of Science, Suranaree University of Technology Nakhon Ratchasima 30000 Thailand anyanee@sut.ac.th.
Nipha ChaicharoenaudomrungLaboratory of Cell-Based Assays and Innovations, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology Nakhon Ratchasima 30000 Thailand.
Oratai WeeranantanapanSchool of Preclinical Sciences, Institute of Science, Suranaree University of Technology Nakhon Ratchasima 30000 Thailand.
Parinya NoisaLaboratory of Cell-Based Assays and Innovations, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology Nakhon Ratchasima 30000 Thailand.ORCID https://orcid.org/0000-0002-1474-7792
Anyanee KamkaewSchool of Chemistry, Institute of Science, Suranaree University of Technology Nakhon Ratchasima 30000 Thailand anyanee@sut.ac.th.ORCID https://orcid.org/0000-0003-1203-2686
Maharat Nakhon Ratchasima Hospital · THShanghai Institute for Science of Science · CNBioClinica (United States) · USNational Science and Technology Development Agency · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Near infrared (NIR) fluorescent dyes that are widely used for cancer imaging usually suffer from their hydrophobicity. To overcome this problem, a water-suspendable and biodegradable NIR-light-activating aza-BODIPY (AZB-NO

Identifiers

PMID35558043
PMCPMC9090774
OpenAlexW2901937538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.